ÂÜÀòÂÒÂ×

Michael Bonney is a seasoned pharmaceutical executive with significant leadership experience, notably as Executive Chair and Chair and CEO at Kaleido Biosciences from June 2017 to October 2020. Prior to this role, Michael served as a retired professional at Cubist Pharmaceuticals. Michael earned a Bachelor of Arts degree in Economics from Bates College, completing the program between 1976 and 1980.